|
|
Reference
|
|
 
|
Battistini, B., D'Orleans-Juste, P., Sirois, P. (1993) Endothelins: Circulating plasma levels and presence in other biologic fluids. Lab Invest, 68(6): 600-28
|
|
|
Benigni, A., Remuzzi, G. (1998) Endothelin receptor antagonists: Which are the therapeutic perspectives in renal diseases?. Nephrol Dial Transplant, 13(1): 5-7
|
|
|
Bird, J.E., Webb, M.L., Wasserman, A.J., Liu, E.C., Giancarli, M.R., Durham, S.K. (1995) Comparison of a novel ETA receptor antagonist and phosphoramidon in renal ischemia. Pharmacology, 50(1): 9-23
|
|
|
Clozel, M., Breu, V., Burri, K., Cassal, J.M., Fischli, W., Gray, G.A., Hirth, G., Loffler, B.M., Muller, M., Neidhart, W. (1993) Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature, 365(6448): 759-61
|
|
|
Gandhi, C.R., Berkowitz, D.E., Watkins, W.D. (1994) Endothelins. Biochemistry and pathophysiologic actions. Anesthesiology, 80(4): 892-905
|
|
|
Gellai, M., Jugus, M., Fletcher, T., DeWolf, R., Nambi, P. (1994) Reversal of postischemic acute renal failure with a selective endothelinA receptor antagonist in the rat. J Clin Invest, 93(2): 900-6
|
|
|
Gellai, M., DeWolf, R., Pullen, M., Nambi, P. (1994) Distribution and functional role of renal ET receptor subtypes in normotensive and hypertensive rats. Kidney Int, 46(5): 1287-94
|
|
|
Gellai, M., Jugus, M., Fletcher, T., Nambi, P., Ohlstein, E.H., Elliott, J.D., Brooks, D.P. (1995) Nonpeptide endothelin receptor antagonists. V: Prevention and reversal of acute renal failure in the rat by SB 209670. J Pharmacol Exp Ther, 275(1): 200-6
|
|
|
Herrero, I., Torras, J., Riera, M., Condom, E., Coll, O., Cruzado, J.M., Hueso, M., Bover, J., Lloberas, N., Alsina, J., Grinyo, J.M. (1999) Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation. Nephrol Dial Transplant, 14(4): 872-80
|
|
|
Hocher, B., Rohmeiss, P., Diekmann, F., Zart, R., Vogt, V., Schiller, S., Bauer, C., Koppenhagen, K., Distler, A., Gretz, N. (1995) Distribution of endothelin receptor subtypes in the rat kidney. Renal and haemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan. Eur J Clin Chem Clin Biochem, 33(8): 463-72
|
|
|
Karet, F.E., Kuc, R.E., Davenport, A.P. (1993) Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Kidney Int, 44(1): 36-42
|
|
|
Kohan, D.E. (1993) Endothelins in the kidney: Physiology and pathophysiology. Am J Kidney Dis, 22(4): 493-510
|
|
|
Kusaka, H., Nomura, H., Karasawa, A. (1994) Effects of benidipine on renal function in anesthetized spontaneously hypertensive rats. Jpn J Pharmacol, 66(1): 81-6
|
|
1
|
Kusumoto, K., Kubo, K., Kandori, H., Kitayoshi, T., Sato, S., Wakimasu, M., Watanabe, T., Fujino, M. (1994) Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in rats. Life Sci, 55(4): 301-10
|
|
|
Lieberthal, W. (1997) Biology of acute renal failure: Therapeutic implications. Kidney Int, 52(4): 1102-15
|
|
|
Lopez-Farre, A., Gomez-Garre, D., Bernabeu, F., Lopez-Novoa, J.M. (1991) A role for endothelin in the maintenance of post-ischaemic renal failure in the rat. J Physiol, 444: 513-22
|
|
|
Mandal, A.K., Bell, R.D., Parker, D., Nordquist, J.A., Lindeman, R.D. (1977) An analysis of the relationship of malignant lesions of the kidney to hypertension. Microvasc Res, 14(3): 279-92
|
|
|
Mandal, A.K., Haygood, C.C., Bell, R.D., Sethney, T., James, T.M., Nordquist, J.A., Yunice, A.A., Lindeman, R.D. (1978) Effects of acute and chronic splenectomy on experimental acute renal tubular lesions. J Lab Clin Med, 92(5): 698-711
|
|
|
Miyauchi, T., Masaki, T. (1999) Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol, 61: 391-415
|
|
1
|
Nissenson, A.R. (1998) Acute renal failure: Definition and pathogenesis. Kidney Int Suppl, 66: S7-10
|
|
|
Pacheco, Y.G., Belloni, A.S., Malendowicz, L.K., Meneghelli, V., Gottardo, G., Nussdorfer, G.G. (1996) Endothelin-1 inhibits renin release from rat kidney acting via ETA receptor subtype. Biomedical research, 17(6), 429-34
|
|
|
Ruschitzka, F., Shaw, S., Gygi, D., Noll, G., Barton, M., Luscher, T.F. (1999) Endothelial dysfunction in acute renal failure: Role of circulating and tissue endothelin-1. J Am Soc Nephrol, 10(5): 953-62
|
|
|
Shibouta, Y., Suzuki, N., Shino, A., Matsumoto, H., Terashita, Z., Kondo, K., Nishikawa, K. (1990) Pathophysiological role of endothelin in acute renal failure. Life Sci, 46(22): 1611-8
|
|
|
Star, R.A. (1998) Treatment of acute renal failure. Kidney Int, 54(6): 1817-31
|
|
|
Tomita, K., Ujiie, K., Nakanishi, T., Tomura, S., Matsuda, O., Ando, K., Shichiri, M., Hirata, Y., Marumo, F. (1989) Plasma endothelin levels in patients with acute renal failure. N Engl J Med, 321(16): 1127
|
|
|
Vemulapalli, S., Chiu, P.J., Chintala, M., Bernardino, V. (1993) Attenuation of ischemic acute renal failure by phosphoramidon in rats. Pharmacology, 47(3): 188-93
|
|
|
Wilhelm, S.M., Simonson, M.S., Robinson, A.V., Stowe, N.T., Schulak, J.A. (1999) Endothelin up-regulation and localization following renal ischemia and reperfusion. Kidney Int, 55(3): 1011-8
|
|
 7
|
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., Masaki, T. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332(6163): 411-5
|
|
|
|
|